Virginia L Smith-Swintosky

USPTO Granted Patents = 13 (Patent Applications = 1)

CIPO Patents = 1

EPO Patents = 10 (Patent Applications = 2)

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 51(Granted Patents)

Company Filing History:

6 out of 363

Ortho-mcneil Pharmaceutical Corp.

patents

6 out of 2,076

Janssen Pharmaceutica Nv

patents

1 out of 271

Johnson & Johnson Consumer Companies, Inc.

patents

Years Active: 2005-2015

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8937096 - Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder (2015-01-20),

2. 8853263 - Co-therapy for the treatment of epilepsy and related disorders (2014-10-07),

3. 8716231 - Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain (2014-05-06),

4. 8691867 - Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction (2014-04-08),

5. 8501791 - 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators (2013-08-06),

6. 8497298 - Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels (2013-07-30),

7. 8492431 - Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity (2013-07-23),

8. 7786311 - 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators (2010-08-31),

9. 7375123 - 1,2,4-thiadiazole derivatives as melanocortin receptor modulators (2008-05-20),

10. 7319107 - 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators (2008-01-15),

11. 7259146 - Neuroprotective peptides (2007-08-21),

12. 7049331 - 1,2,4-thiadiazole derivatives as melanocortin receptor modulators (2006-05-23),

13. 6908902 - Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin (2005-06-21),

Title: The Innovations of Virginia L. Smith-Swintosky

Introduction

Virginia L. Smith-Swintosky is an accomplished inventor based in Hatfield, Pennsylvania, recognized for her significant contributions to pharmaceutical advancements. With a remarkable portfolio of 13 patents, she has made strides in the fields of psychiatry and neurology through her innovative research and development efforts.

Latest Patents

Among her notable recent patents are the following:

1. **Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder** - This invention presents a novel method for treating mania and/or bipolar disorder by administering effective amounts of benzo-fused heterocycle sulfamide derivatives.

2. **Co-therapy for the treatment of epilepsy and related disorders** - This invention focuses on co-therapy that involves administering benzo-fused heterocycle sulfamide derivatives alongside traditional anticonvulsant and/or anti-epileptic agents to enhance treatment efficacy.

Career Highlights

Virginia has worked with prestigious companies such as Ortho-McNeil Pharmaceutical Corporation and Janssen Pharmaceutica NV, where she honed her skills in drug development and innovation. Her efforts have not only contributed to the companies' successes but have also positively impacted patient care in significant ways.

Collaborations

Throughout her career, Virginia has collaborated with esteemed colleagues like Allen B. Reitz and Carlos Plata-Salaman. These partnerships have fostered an environment of innovation and creativity, leading to groundbreaking advancements in therapeutic methods.

Conclusion

Virginia L. Smith-Swintosky exemplifies the spirit of innovation within the pharmaceutical industry. Her extensive patent portfolio and collaborative work with leading researchers showcase her dedication to improving mental health treatments. Through her inventions, she continues to pave the way for future advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.